跳到内容
hiliver.cn学术分享

学术分享

  • 使用手册
  • 常用静脉泵入药物
  • 门诊常用ICD编码
  • 指南&共识
  • 临床工具
  • 关于
login
hiliver.cn学术分享

学术分享

登录
业务学习

Efficacy and safety of frontline systemic therapy for advanced HCC: A network meta-analysis of landmark phase III trials

作者Dr_WangR 2023-06-202023-06-20

Fulgenzi CAM, Scheiner B, Korolewicz J, Stikas CV, Genn…

阅读更多 Efficacy and safety of frontline systemic therapy for advanced HCC: A network meta-analysis of landmark phase III trials继续

业务学习

Diagnostic Performance of Noninvasive Tests for Advanced Hepatic Fibrosis in Young Age Population

作者Dr_MaYH 2023-06-202023-06-20

Kim M, Yoon EL, Lee J, Cho S, Lee CM, Kang BK, Park H, …

阅读更多 Diagnostic Performance of Noninvasive Tests for Advanced Hepatic Fibrosis in Young Age Population继续

业务学习

Clinical pattern of checkpoint inhibitor-induced liver injury in a multicentre cohort

作者Dr_LiP 2023-06-202023-06-20

Hountondji L, Ferreira De Matos C, Lebossé F, Quantin X…

阅读更多 Clinical pattern of checkpoint inhibitor-induced liver injury in a multicentre cohort继续

业务学习|指南与共识

Gender differences of authors of major Hepatology society guidelines during the past 15 years

作者Dr_LiW 2023-06-202023-06-20

Tang X, Luo B, Huang S, Jiang J, Chen Y, Shi X, Zhang W…

阅读更多 Gender differences of authors of major Hepatology society guidelines during the past 15 years继续

业务学习|脂肪肝

Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study

作者Dr_WangLL 2023-06-202023-06-20

Vali Y, Lee J, Boursier J, Petta S, Wonders K, Tiniakos…

阅读更多 Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study继续

未分类

 MRI-AST (MAST) Score Accurately Predicts Major Adverse Liver Outcome, Hepatocellular Carcinoma, Liver Transplant, and Liver-Related Deat

作者Dr_HanF 2023-05-292023-05-29

Emily Truong 1, Jeffrey A Gornbein 2, Ju Dong Yang 3, N…

阅读更多  MRI-AST (MAST) Score Accurately Predicts Major Adverse Liver Outcome, Hepatocellular Carcinoma, Liver Transplant, and Liver-Related Deat继续

页面导航

1 2 3 … 20 下一页下一页

2018年修订版 2021 2022 ACLF AIH CNN ELM PBC SVM UDCA 临床治愈 乙肝 二级预防 人工智能 他汀 低分子肝素 保肝 免疫调节剂 减重 利伐沙班 利拉鲁肽 吸烟 围手术期 干扰素 抗凝 抗血栓 指南 桥接 溶栓 特利加压素 糖尿病 肝病 肝癌 肝硬化 肝纤维化 肝肿瘤 胆血症 脂肪肝 药物 运动 门脉血栓 防治指南 静脉曲张 饮食 高血压

TikTok Github Instagram Facebook Twitter

备案号:津ICP备2022007313号

© 2026 hiliver.cn学术分享

滚动到顶部
  • 使用手册
  • 常用静脉泵入药物
  • 门诊常用ICD编码
  • 指南&共识
  • 临床工具
  • 关于
搜索